Sirio Pharma (SHE:300791) — Market Cap & Net Worth
Market Cap & Net Worth: Sirio Pharma (300791)
Sirio Pharma (SHE:300791) has a market capitalization of $802.72 Million (CN¥5.49 Billion) as of October 16, 2026. Listed on the SHE stock exchange, this China-based company holds position #9723 globally and #2469 in its home market, demonstrating a -3.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sirio Pharma's stock price CN¥17.85 by its total outstanding shares 307318960 (307.32 Million).
Sirio Pharma Market Cap History: 2019 to 2026
Sirio Pharma's market capitalization history from 2019 to 2026. Data shows change from $874.90 Million to $802.72 Million (-4.57% CAGR). Check 300791 stock price and chart for real-time trading data and today's change.
Sirio Pharma Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sirio Pharma's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see how efficiently does Sirio Pharma generate cash for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.28x
Sirio Pharma's market cap is 0.28 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.64x
Sirio Pharma's market cap is 3.64 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $874.90 Million | $1.58 Billion | $142.53 Million | 0.55x | 6.14x |
| 2020 | $1.96 Billion | $2.07 Billion | $257.37 Million | 0.95x | 7.63x |
| 2021 | $1.35 Billion | $2.37 Billion | $231.83 Million | 0.57x | 5.81x |
| 2022 | $1.21 Billion | $2.51 Billion | $212.29 Million | 0.48x | 5.69x |
| 2023 | $1.15 Billion | $3.58 Billion | $281.04 Million | 0.32x | 4.09x |
| 2024 | $1.18 Billion | $4.21 Billion | $325.06 Million | 0.28x | 3.64x |
Competitor Companies of 300791 by Market Capitalization
Companies near Sirio Pharma in the global market cap rankings as of October 16, 2026. See 300791 net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to Sirio Pharma by market ranking:
- Nestlé S.A (F:NESM): Ranked #89 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #105 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #588 globally with a market cap of $46.09 Billion USD ( €39.42 Billion EUR).
- Danone SA (F:BSND): Ranked #686 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Nestlé S.A | F:NESM | $224.33 Billion | €86.80 |
| #105 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF81.07 |
| #588 | Danone SA | PA:BN | $46.09 Billion | €61.22 |
| #686 | Danone SA | F:BSND | $39.61 Billion | €11.90 |
Sirio Pharma Historical Marketcap From 2019 to 2026
Between 2019 and today, Sirio Pharma's market cap moved from $874.90 Million to $ 802.72 Million, with a yearly change of -4.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥802.72 Million | -30.97% |
| 2025 | CN¥1.16 Billion | -1.79% |
| 2024 | CN¥1.18 Billion | +2.92% |
| 2023 | CN¥1.15 Billion | -4.68% |
| 2022 | CN¥1.21 Billion | -10.36% |
| 2021 | CN¥1.35 Billion | -31.46% |
| 2020 | CN¥1.96 Billion | +124.53% |
| 2019 | CN¥874.90 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 16th, 2026 the market cap of Sirio Pharma was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $802.72 Million USD |
| MoneyControl | $802.72 Million USD |
| MarketWatch | $802.72 Million USD |
| marketcap.company | $802.72 Million USD |
| Reuters | $802.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sirio Pharma
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. … Read more